Skip to main content
Clinical Trials/CTRI/2023/03/050735
CTRI/2023/03/050735
Completed
Phase 2

A prospective, open label, one arm clinical study to evaluate the safety and efficacy of Retractable Kohl Kajal in healthy female volunteers

Sunshine Industries0 sites20 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Sunshine Industries
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
April 10, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Sunshine Industries

Eligibility Criteria

Inclusion Criteria

  • 1\.Female subjects between the age group of 18 to 50 years.
  • 2\.Subjects who are able to give written informed consent and ready to comply with the protocol.
  • 3\.Subjects who are regular users of kajal or eye liner

Exclusion Criteria

  • 1\.Subjects who are visually impaired or having underlying conditions that potentially impairs their vision.
  • 2\.Subjects with known history of allergies or specific allergic reactions upon using ophthalmic cosmetic products.
  • 3\.Subjects with presenting ophthalmic conditions like dry eye, cataract, conjunctivitis etc.
  • 4\.Subjects who are regular users of prescription or cosmetic contact lens.
  • 5\.Subjects who have dark circles under their eyes.
  • 6\.Subjects who are reported pregnant/planning a pregnancy or lactating.
  • 7\.Subjects who are currently enrolled in an active investigational study or have participated in an investigational study within 30 days prior to enrolment.
  • 8\.Subjects, who in the opinion of the Investigator or the Expert Dermatologist are not eligible for enrolment in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials